Articles dans des revues avec comité de lecture (396)
  1. 361. Ferreira Filho, A. F., Di Leo, A., Paesmans, M., Beauduin, M., Vindevoghel, A., Michel, J., Focan, C., Awada, A., Cardoso, F., Dolci, S., Bartholomeus, S., & Piccart-Gebhart, M. (2002). The feasibility of classical cyclophophamide, methotrexate, 5-fluorouracil (CMF) for pre- and post-menopausal node-positive breast cancer patients in a Belgian multicentric trial: A study of consistency in relative dose intensity (RDI) and cumulative doses across institutions. Annals of oncology, 13(3), 416-421. doi:10.1093/annonc/mdf051
  2. 362. Genot-Klastersky, M. T., Sekkaki, N., Crombez, P., Awada, A., Bron, D., & Klastersky, J. (2002). Low energy laser irradiation for the treatment of chemotherapy induced mucositis in bone marrow stem cell transplanted patients. Supportive care in cancer, 10, 32.
  3. 363. Ferreira Filho, A. F., Cardoso, F., Di Leo, A., Awada, A., da Silva, V. D. P. R., Tovar, R. B., & Schwartsmann, G. (2001). Carcinomatous meningitis as a clinical manifestation of pancreatic carcinoma. Annals of oncology, 12(12), 1757-1759.
  4. 364. Eskens, F. A., Awada, A., Cutler, D. L., de Jonge, M. J., Luyten, G. P., Faber, M., Statkevich, P., Sparreboom, A., Verweij, J., Hanauske, A.-R., Piccart-Gebhart, M., & European Organization for Research and Treatment of Cancer Early Clinical Studies Group, (2001). Phase I and pharmacokinetic study of the oral farnesyl transferase inhibitor SCH 66336 given twice daily to patients with advanced solid tumors. Journal of clinical oncology, 19(4), 1167-1175.
  5. 365. Awada, A. (2001). Cisplatin/Epinephrine injectable gel: (a viewpoint). Drugs & aging, 18(10), 794.
  6. 366. Awada, A. (2001). Développement des nouveaux agents anticancéreux: dix ans de recherche clinique active marquée par l'évolution du traitement, de l'empirisme au rationnel. Bulletin et mémoires de l'Académie royale de médecine de Belgique, 156(6 Pt 2), 338-347.
  7. 367. Forget, F., Awada, A., & Klastersky, J. (2001). Anticancer chemotherapy in a patient with prior history of acute intermittent porphyria: A case report and review of the literature. Supportive care in cancer, 9(6), 465-466. doi:10.1007/s005200000232
  8. 368. Ferreira Filho, A. F., Cardoso, F., Di Leo, A., Awada, A., da Silva, V. D. P. R., Tovar, R. B., & Schwartsmann, G. (2001). Carcinomatous meningitis as a clinical manisfestation of pancreatic carcinoma. Annals of oncology, 12(12), 1757-1759. doi:10.1023/A:1013532930596
  9. 369. Wohaibi, M. A., Russell, N. A., Ferayan, A. A., Awada, A., Jumah, M. A., & Omojola, M. (2000). Pituitary apoplexy presenting as massive subarachnoid hemorrhage. Journal of neurology, neurosurgery and psychiatry, 69(5), 700-701.
  10. 370. Awada, A., & Piccart-Gebhart, M. (2000). Strategies offering protection from the toxic effects of anticancer treatments with a focus on chemoprotective agents. Current opinion in oncology, 12(4), 289-296.
  11. 371. Paridaens, R., Biganzoli, L., Bruning, P., Klijn, J. G., Gamucci, T., Houston, S., Coleman, R., Schachter, J., Van Vreckem, A., Sylvester, R., Awada, A., Wildiers, J., & Piccart-Gebhart, M. (2000). Paclitaxel versus doxorubicin as first-line single-agent chemotherapy for metastatic breast cancer: a European Organization for Research and Treatment of Cancer Randomized Study with cross-over. Journal of clinical oncology, 18(4), 724-733. doi:10.1200/jco.2000.18.4.724
  12. 372. Pavlidis, N., Aamdal, S., Awada, A., Calvert, H., Fumoleau, P., Sorio, R., Punt, C., Verweij, J., van Oosterom, A., Morant, R., Wanders, J., & Hanauske, A.-R. (2000). Carzelesin phase II study in advanced breast, ovarian, colorectal, gastric, head and neck cancer, non-Hodgkin's lymphoma and malignant melanoma: a study of the EORTC early clinical studies group (ECSG). Cancer chemotherapy and pharmacology, 46(2), 167-171.
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 Suivant >>